Investing.com - Novartis ADR reported on Tuesday second quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Novartis ADR announced earnings per share of $1.36 on revenue of $11.35B. Analysts polled by Investing.com anticipated EPS of $1.34 on revenue of $11.9B.
Novartis ADR shares are down 7.05% from the beginning of the year and are trading at $88.01 , down-from-52-week-high.They are under-performing the EUR/USD which is down 0% from the start of the year.
Novartis ADR follows other major Healthcare sector earnings this month
Novartis ADR's report follows an earnings beat by J&J on Thursday, who reported EPS of $1.67 on revenue of $18.34B, compared to forecasts EPS of $1.49 on revenue of $17.61B.
Abbott Labs had beat expectations on Thursday with second quarter EPS of $0.57 on revenue of $7.33B, compared to forecast for EPS of $0.42 on revenue of $6.81B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar